Resource utilization among kidney transplant recipients.

BACKGROUND Hospitalization consumes a significant portion of the end-stage renal disease (ESRD) program, which includes kidney transplant recipients. Identification of kidney transplant recipients at risk of increased resource utilization could lead to appropriate interventions to attenuate the complications related to kidney transplant, which may reduce resource utilization. METHODS This retrospective cohort study of kidney transplant recipients was performed to identify risk factors for hospital utilization. The study population consisted of patients who received kidney transplant at our center between October 1990 and September 1999 and were followed in the outpatient clinic. RESULTS Of the 220 patients, 171 (78%) were hospitalized during a median follow-up of 36 months. The number of hospitalizations, hospital days, and outpatient visits per patient-year at risk were 1.1, 6.3, and 21.6, respectively. Infection episodes were the leading cause of hospitalization. In a multivariate regression analysis, cytomegalovirus (CMV)-positive status of donor (RR 1.58; 95% CI 1.15, 2.18) and a higher number of hospital days during the transplant hospitalization (RR 1.10 per 7 days increase; 95% CI 1.03, 1.19) were associated with a higher risk of hospitalization, while higher serum albumin (RR 0.84 per 0.5 g/dL increase; 95% CI 0.73, 0.97), higher hematocrit (RR 0.95 per 1% increase; 95% CI 0.92, 0.98), higher glomerular filtration rate (GFR) (RR 0.91 per 10 mL/min/1.73 m2; 95% CI 0.85, 0.99), and an increased interval since transplant (RR 0.84 per 6 months increase; 95% CI 0.75, 0.93) were associated with a lower risk of hospitalization. CMV-positive status of the donor (RR 1.11; 95% CI 1.00, 1.21) and presence of cardiovascular disease (RR 1.12; 95% CI 1.00, 1.24) were associated with a higher risk of outpatient visits, while Caucasian race (RR 0.82; 95% CI 0.73, 0.94), higher serum albumin (RR 0.88 per 0.5 g/dL increase; 95% CI 0.84, 0.93), higher hematocrit (RR 0.96 per 1% increase; 95% CI 0.95, 0.97), and an increased interval since transplant (RR 0.79 per 6 months increase; 95% CI 0.76, 0.83) were associated with a lower risk of outpatient visits. CONCLUSION Identification of risk factors associated with increase resource utilization among kidney transplant recipients could aid in the development of targeted interventions to improve clinical and economic outcomes.

[1]  Graves Ej,et al.  National Hospital Discharge Survey , 2004 .

[2]  H. Tighiouart,et al.  Health care utilization among patients with chronic kidney disease. , 2002, Kidney international.

[3]  A. Kausz,et al.  Opportunities to improve the care of patients with kidney transplant failure. , 2002, Kidney international.

[4]  R. Poveda,et al.  Goodpasture syndrome during the course of a Schönlein-Henoch purpura. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  M. Bernabeu-Wittel,et al.  Infections in Renal Transplant Recipients Receiving Mycophenolate Versus Azathioprine-Based Immunosuppression , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[6]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  A. Collins,et al.  Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%. , 2001, Journal of the American Society of Nephrology : JASN.

[8]  P. Cullen.  Evidence that triglycerides are an independent coronary heart disease risk factor. , 2000, The American journal of cardiology.

[9]  S. Rostand.  Coronary heart disease in chronic renal insufficiency: some management considerations. , 2000, Journal of the American Society of Nephrology : JASN.

[10]  L. Kozak,et al.  National hospital discharge survey: annual summary, 1998. , 2000, Vital and health statistics. Series 13, Data from the National Health Survey.

[11]  D. Holland,et al.  Predictors of hospitalization and death among pre-dialysis patients: a retrospective cohort study. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  A. Kausz,et al.  Hospital utilization among chronic dialysis patients. , 2000, Journal of the American Society of Nephrology : JASN.

[13]  S. Mulgaonkar,et al.  Infectious complications in geriatric renal transplant patients: comparison of two immunosuppressive protocols. , 1999, Transplantation.

[14]  G. Becker,et al.  Impact of acute rejection therapy on infections and malignancies in renal transplant recipients. , 1999, Transplantation.

[15]  A. Matas,et al.  Features of acute rejection that increase risk for chronic rejection. , 1999, Transplantation.

[16]  J. Fink,et al.  Increased incidence of postoperative infections associated with peritoneal dialysis in renal transplant recipients. , 1999, Transplantation.

[17]  R. Foley,et al.  Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease and cardiac failure. Semin Dial 2003 , 2022 .

[18]  A. Collins,et al.  Hematocrit levels and hospitalization risks in hemodialysis patients. , 1999, Journal of the American Society of Nephrology : JASN.

[19]  R. Foley,et al.  Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  J. Gómez-Moreno,et al.  Infection in organ-transplant recipients. , 1998, The New England journal of medicine.

[21]  J. Heaf,et al.  The effect of acute rejection on long-term renal graft survival is mainly related to initial renal damage , 1998 .

[22]  F. Cosio,et al.  Impact of acute rejection and early allograft function on renal allograft survival. , 1997, Transplantation.

[23]  M. Rocco,et al.  Risk factors for hospital utilization in chronic dialysis patients. Southeastern Kidney Council (Network 6). , 1996, Journal of the American Society of Nephrology : JASN.

[24]  P. Kimmel,et al.  Relative risk and economic consequences of inpatient care among patients with renal failure. , 1996, Journal of the American Society of Nephrology : JASN.

[25]  G. Shearer,et al.  Mechanisms of hypoalbuminemia in hemodialysis patients. , 1995, Kidney international.

[26]  Gary G. Koch,et al.  Categorical Data Analysis Using The SAS1 System , 1995 .

[27]  W. Land,et al.  Positive donor and negative recipient cytomegalovirus status is a detrimental factor for long‐term renal allograft survival , 1994, Transplant international : official journal of the European Society for Organ Transplantation.

[28]  Graves Ej,et al.  National Hospital Discharge Survey: annual summary, 1992. , 1994, Vital and health statistics. Series 13, Data from the National Health Survey.

[29]  A. Gaber,et al.  Factors affecting erythropoietin production and correction of anemia in kidney transplant recipients. , 1994, Clinical transplantation.

[30]  R. Rubin.  Infectious disease complications of renal transplantation. , 1993, Kidney international.

[31]  K. Iseki,et al.  Serum albumin is a strong predictor of death in chronic dialysis patients. , 1993, Kidney international.

[32]  E G Lowrie,et al.  Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  A. Besarab,et al.  Dynamics of erythropoiesis following renal transplantation. , 1987, Kidney international.

[34]  L. Kääriäinen,et al.  Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis. , 1965, British medical journal.

[35]  K Doqi,et al.  clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification , 2002 .

[36]  M. Seshadri,et al.  Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[37]  B. Kasiske,et al.  Serum albumin and mortality after renal transplantation. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  G. Shearer,et al.  Mechanisms of hypoalbuminemia in hemodialysis patients (Kidney International 48: (510-516)) , 1995 .

[39]  M. Mcgeown,et al.  The initiation of erythropoiesis following renal transplantation. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.